Table 4. Differences in variables at the end of the study following intervention between the groups.

Variables	Group 1	Group 2	Group 3	Group 4	p value
MDA (ng/mL)	-0.4 ± 0.8*	-0.9 ± 0.7*	-0.2 ± 0.5	0.3 ± 0.6	<0.01
SOD (U/gHb)	27.4 ± 10.2*	12.3 ± 14.0*	23.5 ± 5.9*	1.9 ± 1.1	0.01
GPx (U/gHb)	28.4 ± 2.5*	11.8 ± 2.7*	25.2 ± 0.8*	2.0 ± 0.0	<0.01
TAC (mg/dL)	0.4 ± 0.4*	-0.1 ± 0.4	0.02 ± 0.4	-0.2 ± 0.4	0.04
FBS(mg/dL)	-29.0 ± 29.1	-20.7 ± 25.4	-13.2 ± 22.1	-20.5 ± 26.1	0.26
HbA1c %	-0.7 ± 0.9	-0.7 ± 1.2	-1.0 ± 0.7	-1.0 ± 1.6	0.74
TG (mg/dL)	-31.3 ± 31.3*	-24.2 ± 40.6	-25.5 ± 18.4	-18.6 ± 21.5	0.02
Vitamin C(mg/dL)	0.2 ± 0.2	0.4 ± 0.2*	-0.05 ± 0.1	-0.03 ± 0.04	0.04

x-bar ± SD. General linear model (ANCOVA) was used to assess treatment effects between groups adjusted for age, BMI, duration of diagnosed diabetes and baseline valuse. Bonferroni correction was used wherever there is a main effect. *Significant changes for each of the three treatment groups relative to the placebo group. [EPA= eicosapentaenoic acid; MDA= Malondialdehyde; SOD= Superoxide Dismutase; G-PX= Glutathione Peroxidase; TAC= Total Capacity of Antioxidant; FBS= Fasting blood sugar; HbA1c = Glycosylated hemoglobin; TG= Triglyceride].